Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...
Approaches incorporating rapid or digital PCR, CRISPR, syndromic testing, and multimodal systems reached new milestones this year.
Attendees interested in learning more about CoSara products, including the TB and HPV tests on the Company's upcoming Co-Dx PCR platform, are encouraged to stop by at VIROCON 2025. CoSara will be ...
The FDA has approved three self-administered tests for the high-risk strains of HPV known to cause most cervical cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback